Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression

Bibliography

• Craven R. Ketamine. Anaesthesia 2007;62(Suppl 1):48-53
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Reaction and significance of cytochrome P-450 enzymes. J Biol Chem 1991;266:10019-22
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signaling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-60
   PubMed Web of Science ®Google Scholar
• Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 2002;30:853-8
   PubMed Web of Science ®Google Scholar
• Kimura F, Hashimoto Y, Shimodate Y. Clinical study on total intravenous anaesthesia with droperidol, fentanyl and ketamine. Hepatic and renal functions following prolonged surgical operation of over 10 h. Masui 1991;40:1371-5
   PubMedGoogle Scholar
• Lee ST, Wu TT, Yu PY, Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. Br J Anaesth 2009;102:80-9
   PubMed Web of Science ®Google Scholar
• Martínez-Jiménez CP, Jover R, Donato MT, Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab 2007;8:185-94
   PubMed Web of Science ®Google Scholar
• Chang HC, Chen TL, Chen RM. Cytoskeleton interruption in human hepatoma HepG2 cells induced by ketamine occurs possibly through suppression of calcium mobilization and mitochondrial function. Drug Metab Dispos 2009;37:24-31
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Martin MV, Beaune PH, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 1986;261:5051-60
   PubMed Web of Science ®Google Scholar
• Acharya P, Engel JC, Correia MA. Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2 eIF2alpha kinase (GCN2), and global translational shutoff. Mol Pharmacol 2009;76:503-15
   PubMed Web of Science ®Google Scholar
• Brian P, Monahan MD, Clifford L, Torsades de Pointes occurring in association with terfenadine use. JAMA 1990;264:2788-90
   PubMed Web of Science ®Google Scholar
• Canton DA, Litchfield DW. The shape of things to come: an emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal 2006;18:267-75
   PubMed Web of Science ®Google Scholar
• Gourlay CW, Ayscough KR. The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 2005;6:583-9
   PubMed Web of Science ®Google Scholar
• Adrain C, Duriez PJ, Brumatti G, The cytotoxic lymphocyte protease, granzyme B, targets the cytoskeleton and perturbs microtubule polymerization dynamics. J Biol Chem 2006;281:8118-25
   PubMed Web of Science ®Google Scholar
• Cherng YG, Chang HC, Lin YL, Apoptotic insults to human chondrocytes induced by nitric oxide are involved in sequential events, including cytoskeletal remodeling, phosphorylation of mitogen-activated protein kinase kinase kinase-1, and Bax-mitochondria-mediated caspase activation. J Orthop Res 2008;26:1018-26
   PubMed Web of Science ®Google Scholar
• Dvorak Z, Ulrichova J, Modriansky M. Role of microtubules network in CYP genes expression. Curr Drug Metab 2005;6:545-52
   PubMed Web of Science ®Google Scholar
• Molitoris BA, Dahl R, Hosford M. Cellular ATP depletion induces disruption of the spectrin cytoskeletal network. Am J Physiol 1996;271:790-8
   Google Scholar
• Fache S, Dalous J, Engelund M, Calcium mobilization stimulates Dictyostelium discoideum shear-flow-induced cell motility. J Cell Sci 2005;118:3445-7
   PubMed Web of Science ®Google Scholar
• Papucci L, Schiavone N, Witort E, Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem 2003;278:28220-8
   PubMed Web of Science ®Google Scholar
• Green SM, Klooster M, Harris T, Ketamine sedation for pediatric gastroenterology procedures. J Pediatr Gastroenterol Nutr 2001;32:26-33
   PubMed Web of Science ®Google Scholar
• Bourgoin A, Albanese J, Wereszczynski N, Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med 2003;31:711-17
   PubMed Web of Science ®Google Scholar
• Reich D, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989;36:186-97
   PubMed Web of Science ®Google Scholar
• De Kock MF, Lavand’homme PM. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Prac Res Clin Anaesthesiol 2007;21:85-98
   PubMedGoogle Scholar
• Pekoe GM, Smith DJ. The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine. Pain 1982;12:57-73
   PubMed Web of Science ®Google Scholar
• Cook DJ, Carton EG, Housmans PR. Mechanism of the positive inotropic effect of ketamine in isolated ferret ventricular papillary muscle. Anesthesiology 1991;74:880-8
   PubMed Web of Science ®Google Scholar
• Chen RM, Chen TL, Lin YL, Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells through downregulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit Care Med 2005;33:1044-9
   PubMed Web of Science ®Google Scholar
• Lundy PM, Lockwood PA, Thompson G, Differential effects of ketamine isomers on neuronal and extraneuronal catecholamine uptake mechanisms. Anesthesiology 1986;64:359-63
   PubMed Web of Science ®Google Scholar
• Lau TT, Zed PJ. Does ketamine have a role in managing severe exacerbation of asthma in adults? Pharmacotherapy 2001;21:110-6
   Web of Science ®Google Scholar
• Strayer RJ. Nelson LS. Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med 2008;26:985-1028
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Reaction and significance of cytochrome P-450 enzymes. J Biol Chem 1991;266:10019-22
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signaling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-60
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Cytochrome P450 and chemical toxicology. Chem Res Toxicol 2008;21:70-83
   PubMed Web of Science ®Google Scholar
• Iyer M, Reschly EJ, Krasowski MD. Functional evolution of the pregnane X receptor Export. Expert Opin Drug Metab Toxicol 2006;2:381-97
   PubMed Web of Science ®Google Scholar
• Zhang YY, Yang L. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications. Expert Opin Drug Metab Toxicol. 2009;5:621-9
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Martin MV, Beaune PH, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 1986;261:5051-60
   PubMed Web of Science ®Google Scholar
• Woolf TF, Adams JD. Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations. Xenobiotica 1987;17:839-47
   PubMed Web of Science ®Google Scholar
• Yanagihara Y, Kariya S, Ohtani M, Involvement of CYP2B6 in the N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 2001;29:887-90
   PubMed Web of Science ®Google Scholar
• Wang H, Tompkins LM. CYP2B6: New insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab 2008;9:598-610
   PubMed Web of Science ®Google Scholar
• Chang T, Savory A, Albin M, Metabolic disposition of tritium-labelled ketamine. Clin Res 1970;18:597
   Google Scholar
• Zhou S, Chan E, Lim LY, Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4. Curr Drug Metab 2004;5:415-42
   PubMed Web of Science ®Google Scholar
• Tanaka E. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. J Clin Pharm Ther 1998;23:403-16
   PubMed Web of Science ®Google Scholar
• Bailey DG, Dresser GK, Bend JR. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin Pharmacol Ther 2003;73:529-37
   PubMed Web of Science ®Google Scholar
• Lin JH. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 2006;23:1089-116
   PubMed Web of Science ®Google Scholar
• Plant N. The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks. Biochim Biophys Acta 2007;1770:478-88
   PubMed Web of Science ®Google Scholar
• Li W, Harper PA, Tang BK, Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Biochem Pharmacol 1998;56:599-612
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, D’Costa DJ, Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 2002;62:359-65
   PubMed Web of Science ®Google Scholar
• Gnerre C, Blattler S, Kaufmann MR, Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 2004;14:635-45
   PubMedGoogle Scholar
• Watt AJ, Garrison WD, Duncan SA. HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 2003;37:1249-53
   PubMed Web of Science ®Google Scholar
• Marietta MP, White PF, Pudwill CR, Biodisposition of ketamine in the rat: self-induction of metabolism. J Pharmacol Exp Ther 1976;196:536-44
   PubMed Web of Science ®Google Scholar
• Marietta MP, Vore ME, Way WL, Characterization of ketamine induction of hepatic microsomal drug metabolism. Biochem Pharmacol 1977;26:2451-3
   PubMed Web of Science ®Google Scholar
• Loch JM, Potter J, Bachmann KA. The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo. Pharmacology 1995;50:146-53
   PubMed Web of Science ®Google Scholar
• Meneguz A, Fortuna S, Lorenzini P, Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo. Exp Toxicol Pathol 1999;51:392-6
   PubMed Web of Science ®Google Scholar
• Lupp A, Kerst S, Karge E. Evaluation of possible pro- or antioxidative properties and of the interaction capacity with the microsomal cytochrome P450 system of different NMDA-receptor ligands and of taurine in vitro. Exp Toxicol Pathol 2003;54:441-8
   PubMed Web of Science ®Google Scholar
• Chan WH, Sun WZ, Ueng TH. Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications. J Toxicol Environ Health A 2005;68:1581-97
   PubMed Web of Science ®Google Scholar
• Osaka Y, Inomata S, Tanaka E, Effect of propofol on ropivacaine metabolism in human liver microsomes. J Anesth 2006;20:60-3
   PubMedGoogle Scholar
• Yang LQ, Yu WF, Cao YF, Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003;9:1959-62
   PubMed Web of Science ®Google Scholar
• Pasanen M, Pellinen P, Stenback F, The role of CYP enzymes in cocaine-induced liver damage. Arch Toxicol 1995;69:287-90
   PubMed Web of Science ®Google Scholar
• Willard FS, Crouch MF. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol Cell Biol 2000;78:387-94
   PubMed Web of Science ®Google Scholar
• Janmey PA. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev 1998;78:763-81
   PubMed Web of Science ®Google Scholar
• Németh ZH, Deitch EA, Davidson MT, Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation and inflammatory mediator production in cultured human intestinal epithelial cells. J Cell Physiol 2004;200:71-81
   PubMed Web of Science ®Google Scholar
• Rosette C, Karin M. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol 1995;128:1111-9
   PubMed Web of Science ®Google Scholar
• Dvorák Z, Vrzal R, Ulrichová J, Involvement of cytoskeleton in AhR-dependent CYP1A1 expression. Curr Drug Metab 2006;7:301-13
   PubMed Web of Science ®Google Scholar
• Schöller A, Hong NJ, Bischer P, Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole. Mol Pharmacol 1994;45:944-54
   PubMed Web of Science ®Google Scholar
• Dvorak Z, Modriansky M, Pichard-Garcia L, Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol Pharmacol 2003;64:160-9
   PubMed Web of Science ®Google Scholar
• Modrianský M, Dvorák Z. Microtubule disruptors and their interaction with biotransformation enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:213-5
   PubMedGoogle Scholar
• Zheng X, Diraviyam K, Sept D. Nucleotide effects on the structure and dynamics of actin. Biophys J 2007;93:1277-83
   PubMed Web of Science ®Google Scholar
• Nogales E. Structural insights into microtubule function. Ann Rev Biochem 2000;69:277-302
   PubMed Web of Science ®Google Scholar
• Andrew WH, Linda W. How motor proteins influence microtubule polymerization dynamics. J Cell Sci 2000;113:4379-89
   PubMed Web of Science ®Google Scholar
• Karcher RL, Roland JT, Zappacosta F, Cell cycle regulation of myosin-V by calcium/calmodulin-dependent protein kinase II. Science 2001;293:1317-20
   PubMed Web of Science ®Google Scholar
• Adamíková L, Straube A, Schulz I, Calcium signaling is involved in dynein-dependent microtubule organization. Mol Biol Cell 2004;15:1969-80
   PubMed Web of Science ®Google Scholar
• Rappaport L, Oliviero P, Samuel JL. Cytoskeleton and mitochondrial morphology and function. Mol Cell Biochem 1998;184:101-5
   PubMed Web of Science ®Google Scholar
• Yoon YS, Byun HO, Cho H, Complex II defect via down-regulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescence-associated growth arrest. J Biol Chem 2003;278:51577-86
   PubMed Web of Science ®Google Scholar
• de Cavanagh EM, Ferder M, Inserra F, Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol 2009;296:550-8
   PubMed Web of Science ®Google Scholar
• Markham A, Cameron I, White SJ. The effect of ketamine hydrochloride, a non-barbiturate parenteral anaesthetic on oxidative phosphorylation in rat liver mitochondria. Biochem Pharmacol 1981;30:2165-8
   PubMed Web of Science ®Google Scholar
• Chang Y, Chen TL, Sheu JR, Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol. 2005;204:27-35
   PubMed Web of Science ®Google Scholar
• Pearce LL, Epperly MW, Greenberger JS, Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide. Nitric Oxide 2001;5:128-36
   PubMed Web of Science ®Google Scholar
• Ogawa K, Tanaka S, Murray PA. Inhibitory effects of etomidate and ketamine on endothelium-dependent relaxation in canine pulmonary artery. Anesthesiology 2001;94:668
   PubMed Web of Science ®Google Scholar
• Kamel IR, Wendling WW, Chen D, N-methyl-D-aspartate (NMDA) antagonists–S(+)-ketamine, dextrorphan, and dextromethorphan–act as calcium antagonists on bovine cerebral arteries. J Neurosurg Anesthesiol 2008;20:241-8
   PubMed Web of Science ®Google Scholar
• Haugen DA, Coon MJ. Properties of electrophoretically homogeneous phenobarbital-inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J Biol Chem 1976;251:7929-39
   PubMed Web of Science ®Google Scholar
• Ueng TH, Ueng YF, Tsai JN, Induction and inhibition of cytochrome P-450-dependent monooxygenases in hamster tissues by ethanol. Toxicology 1993;81:145-54
   PubMed Web of Science ®Google Scholar